A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 602 shares of LLY stock, worth $450,302. This represents 0.08% of its overall portfolio holdings.

Number of Shares
602
Previous 78 671.79%
Holding current value
$450,302
Previous $70,000 661.43%
% of portfolio
0.08%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $404,601 - $503,050
524 Added 671.79%
602 $533,000
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $12,322 - $15,453
17 Added 27.87%
78 $70,000
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $34,347 - $45,952
-58 Reduced 48.74%
61 $47,000
Q4 2023

May 06, 2024

BUY
$525.19 - $619.13 $30,461 - $35,909
58 Added 95.08%
119 $69.4 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $62,497 - $73,676
119 New
119 $69.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.